يعرض 81 - 100 نتائج من 38,416 نتيجة بحث عن '(( a non decrease ) OR ((( 50 ((ng decrease) OR (a decrease)) ) OR ( 5 point decrease ))))', وقت الاستعلام: 0.76s تنقيح النتائج
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc حسب Lei Wang (6656)

    منشور في 2025
    "…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …"
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96
  17. 97
  18. 98
  19. 99
  20. 100

    Lower insular perfusion in the DAT group compared with the non-DAT group. حسب Masashi Takeuchi (1930312)

    منشور في 2022
    "…In the region of interest-based analysis, decrease extent ratios were higher in the DAT group (N = 12) than in the non-DAT group (N = 38) (D). …"